Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 ETF (NY:IWM)

218.01 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 ETF

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
iTeos, GSK End Collaboration On Experimental Cancer Therapy Development: But Retail’s Extremely Bullish
The two companies worked together to assess the Belrestotug + Dostarlimab doublet in treating a specific type of lung cancer. 
Via Stocktwits
Topics Government
The Best Russell 2000 ETF to Invest $500 In Right Now
Via The Motley Fool
Topics ETFs Stocks
AST SpaceMobile Stock Slips On Disappointing Q1: Retail Buyers Throng To Buy Dip In This Starlink Rival
CEO Abel Avellan said the company has expanded U.S. government opportunities and is positioned to start generating meaningful revenue in 2025. 
Via Stocktwits
Rigetti Falls On Q1 Miss But Retail Doubles Down On Stock Amid Faith In Quantum Computing Tech
Revenue fell about 52% year over year to $1.47 million, missing the Finchat-compiled consensus estimate of $2.55 million. 
Via Stocktwits
Topics Government
Nasdaq, S&P 500 Futures Dip As Traders Pause For Breather Ahead Of April CPI: Strategist Sees Path To New Highs
Tariff news flow, first-tier economic data, and a few earnings reports could decide the day's trading direction, although the momentum is decisively in favor of further gains. 
Via Stocktwits
Topics Stocks
Magnificent Seven Gain $700B After US-China Slash Tariffs, Gold Crashes: What's Driving Markets Monday?
Under the 90-day reprieve, the U.S. will cut tariffs on Chinese goods; Equities soared, but gold suffered its worst day since November. 
Via Benzinga
Topics World Trade
Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens
The company also reiterated its full-year total revenue guidance of $250 million to $260 million and net product sales guidance of $240 million to $250 million. 
Via Stocktwits
Nasdaq, S&P 500 Futures Spike As Bessent Touts 'Substantial Progress' In China Trade Talks: Analyst Sees 'Huge' Positive For Markets
U.S. Trade Representative Jamieson Greer stated that the speed with which the U.S. and China could reach an agreement showed that perhaps the differences were not as large as initially thought. 
Via Stocktwits
Topics Economy Stocks World Trade
Stocks Slip As Gold Rebounds To $3,330, Bitcoin Holds $102,000: What's Driving Markets Friday?
Wall Street traded slightly lower by midday Friday, as investors adopted a wait-and-see stance ahead of a potential trade breakthrough, with high-stakes negotiations between U.S. officials—led by... 
Via Benzinga
Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish
CEO Shankar Musunuri said that the company is “on track” to meet its goal of submitting applications to the FDA requesting approval for the distribution of three of its products in the next three... 
Via Stocktwits
Topics Lawsuit
Verastem’s Combination Therapy For Ovarian Cancer Gets FDA Approval: Retail’s Pleased
The combination of Avutometinib capsules and Defactinib tablets, under the brand name Avmapki Fakzynja Co-pack, can now be used to treat patients with KRAS-mutated recurrent low-grade serous ovarian... 
Via Stocktwits
Wall Street Rallies After US Seals First Trade Deal: 'You Better Go Out And Buy Stock,' Trump Says
U.S. stocks rallied Thursday after the Trump administration signed its first major trade agreement with the United Kingdom, igniting optimism about further global deals — especially with China — and... 
Via Benzinga
Topics Government
Novavax Stock Rallies On Upbeat Q1 Earnings, Revised Full-Year Revenue Forecast: Retail’s Elated
The company raised its full-year revenue guidance to between $975 million and $1.025 billion, up from its previous guidance of between $300 million and $350 million. 
Via Stocktwits
Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday?
U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Reserve’s upcoming policy decision, with Chair Jerome Powell set to speak at 2:30 p.m. ET. 
Via Benzinga
Topics Economy
EVgo Reports Upbeat Q1 Earnings, CEO Expects Minimal Impact From Trump Tariffs: Retail’s Thrilled
The company also affirmed its full-year revenue guidance of $340 million to $380 million. 
Via Stocktwits
Topics Government World Trade
Stocks Fall On Trade Concerns, Oil And Gold Rally: What's Driving Markets Tuesday?
Wall Street edged lower by midday Tuesday as uncertainty surrounding trade policies lingered, with investors adopting a cautious approach ahead of Wednesday’s Federal Reserve meeting. 
Via Benzinga
Topics Economy
CorMedix Q1 Earnings Trump Estimates: Retail’s Overjoyed
The company reported net revenue of $39.1 million for the first quarter from the sales of DefenCath, above an analyst estimate of $36, as per Finchat data. 
Via Stocktwits
Topics Earnings Government
Nasdaq, S&P 500 Futures Slip As Fed Jitters, Tariff Risks Weigh On Market Mood: Economist Says Investors Pricing In ‘Average Risk’
According to Morgan Stanley's Matt Wilson, the 5,750-5,800 area — the convergence of the 200-day and 100-day moving averages — is the most critical technical test for the S&P 500 Index. 
Via Stocktwits
Topics Economy Stocks
Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday?
Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services... 
Via Benzinga
BioCryst Pharma Stock Soars 10% Pre-Market On Upbeat Q1 Earnings, Improved Full Year Guidance: Retail’s Pleased
BioCryst now expects global net Orladeyo revenue to be between $580 million and $600 million for the full year, up from its previous guidance of between $535 million and $550 million. 
Via Stocktwits
S&P 500, Dow Jones Futures Slip After 9-Day Rally As Fed Decision Looms: Why One Strategist Says Fed Must Act Now
Positive tech earnings have set the tempo for the recent uptrend, and removal of the tariff overhang would further solidify the rally. 
Via Stocktwits
Topics Economy Government Stocks
Nasdaq 100 Leads Wall Street Rally As China Signals Openness To Fentanyl Talks, Easing Trade Tensions
U.S. stocks rose on hopes of China's willingness to negotiate a trade deal regarding fentanyl production. Tech stocks led the rally. 
Via Benzinga
Wall Street Eyes 9th Straight Day Of Gains, Apple Falls As Chinese Sales Disappoint: What's Driving Markets Friday?
U.S. stocks advanced across the board by midday Friday, with the S&P 500 eyeing its ninth consecutive day of gains—poised for the longest winning streak since May 2024. 
Via Benzinga
S&P 500, Dow Futures Surge As China Trade Deal Hopes Offset Big Tech Disappointment — Analyst Tells Why Market May Have Bottomed
The spotlight will likely be on the April non-farm payrolls report. Economists, on average, expect 133,000 job gains for the month, notably slower than the 228,00 pace for March. 
Via Stocktwits
Topics ETFs Economy Stocks
Wall Street Eyes 8th Positive Day As S&P 500 Recoups Tariff-Led Losses, Bitcoin Rallies To $97,000: What's Driving Markets Thursday?
Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning streak since November 2023. The index rose about 1% to 5,560, fully... 
Via Benzinga
Topics Government Stocks World Trade
Nasdaq, Dow Jones Futures Rise On Meta, Microsoft Results: Apple Earnings Loom, Analyst Doubts New Bull Run For Stock Markets
Notwithstanding the recent seven-session run, the S&P 500 Index ended April — a historically strong month — with a loss of 0.8%. 
Via Stocktwits
Topics Economy Stocks World Trade
Regulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From Novartis
According to the terms of the deal, Novartis, through a subsidiary, will initiate a tender offer to acquire all of Regulus' outstanding shares for an initial price of $7.00 per share or $800 million. 
Via Stocktwits
US Stock Futures Slip Ahead Of Meta, Microsoft Earnings, Inflation Print: Strategist Sees Choppy Waters Ahead
Notwithstanding the resurgence seen since last week, the market is likely to end April with a monthly loss, with the S&P 500 down 0.90% with a session to go. 
Via Stocktwits
Topics Economy Government Stocks
Wall Street Falls On Weak Economic Data As Oil Slumps To $58: What's Driving Markets Wednesday
Wall Street traded lower on the final session of the month, heading for its third consecutive monthly loss as economic data began reflecting the impact of Trump tariffs. 
Via Benzinga
Topics Government
Stocks Surge And Bond Yields Fall For 6th Day, Oil Prices Drop To $60: What's Driving Markets Tuesday?
Wall Street modestly up as investors await economic data and corporate earnings. Bond market continues rally, gold and oil prices fall.Wall Street rises modestly, bond market continues rally, gold and... 
Via Benzinga
Topics Bonds
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS